Antiischemic Activity of New Domestic Antioxidant 3-Hydroxypyridine Etoxidol Derivative

Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Т. В. Красилина(National Research Mordovia State University), Е. Д. Гогина(National Research Mordovia State University), M. V. Vertyankin(National Research Mordovia State University), Екатерина Блинова(Sechenov University), Л. Н. Сернов(Institute of Physiologically Active Compounds), Г. Г. Бойко(National Research Mordovia State University), Л. В. Пивкина(National Research Mordovia State University), В. П. Балашов(National Research Mordovia State University), Л. В. Ванькова(National Research Mordovia State University)
Bulletin of Experimental Biology and Medicine
March 1, 2012
10.1007/s10517-012-1581-3
Cited by 7

Related Papers

Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13